Related Experiment Videos
Is analgesic nephropathy still a problem in Belgium?
1Department of Nephrology-Hypertension, University of Antwerpen, Belgium.
Summary
Analgesic nephropathy remains a significant cause of end-stage renal failure in Belgium. A 1984 study found a 17.9% prevalence in dialysis patients, particularly in northern regions, linked to analgesic mixture consumption.
Area of Science:
- Nephrology
- Public Health
- Pharmacology
Background:
- Analgesic nephropathy is a recognized cause of chronic kidney disease.
- Belgium has historically faced challenges with analgesic-induced kidney damage.
Purpose of the Study:
- To determine the prevalence of analgesic nephropathy in Belgian dialysis patients.
- To investigate geographical variations and potential risk factors for analgesic nephropathy.
Main Methods:
- A nationwide survey of 53 out of 54 dialysis centers in Belgium was conducted in 1984.
- A general population survey assessed analgesic medication ownership and abuse patterns.
Main Results:
- The prevalence of analgesic nephropathy among dialysis patients was 17.9%.
- A higher prevalence was observed in northern Belgium, correlating with the use of powdered analgesic mixtures.
- 83% of the general population reported having analgesics at home, with 2.1% identified as abusers, predominantly females using mixtures.
Conclusions:
- Analgesic nephropathy is a substantial contributor to end-stage renal failure in Belgium.
- Geographical disparities and specific analgesic formulations (powdered mixtures) are linked to higher disease prevalence.